Antidepressants and the Risk of Hyponatremia: A Class-by-Class Review of Literature

Psychosomatics

Volumn 55, Issue 6, 2014, Pages 536-547

  de Picker, Livia ^a,c   van Den Eede, Filip ^a,b   Dumont, Glenn ^a,c   Moorkens, Greta ^b   Sabbe, Bernard G C ^a,c  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DULOXETINE; ESCITALOPRAM; FLUOXETINE; GENERIC DRUG; ISOCARBOXAZID; LAXATIVE; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; PHENELZINE; REBOXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; THIAZIDE DIURETIC AGENT; TRANYLCYPROMINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; MIANSERIN;

HUMAN; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; INCIDENCE; LITERATURE; MEDLINE; PATIENT RISK; REVIEW; RISK; RISK FACTOR; STUDY DESIGN; WEB OF SCIENCE; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED;

ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; HUMANS; HYPONATREMIA; MIANSERIN; MONOAMINE OXIDASE INHIBITORS; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; VENLAFAXINE HYDROCHLORIDE;

EID: 84926313694     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2014.01.010     Document Type: Review

References (56)

1. Patterson J.H. The impact of hyponatremia. Pharmacotherapy 2011, 31(5):5S-8S.
2. Liamis G., Milionis H., Elisaf M. A review of drug-induced hyponatremia. Am J Kid Dis 2008, 52(1):144-153.
3. Luzecky M., Burman K., Schultz E. The syndrome of inappropriate secretion of antidiuretic hormone associated with amitriptyline administration. South Med J 1974, 67(4):495-497.
4. Gommans J., Edwards R. Fluoxetine and hyponatraemia. N Z Med J 1990, 103(885):106.
5. Pillans P.I., Coulter D.M. Fluoxetine and hyponatremia-a potential hazard in the elderly. N Z Med J 1994, 107(973):85-86.
6. Degner D., Grohmann R., Kropp S., et al. Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP. Pharmacopsychiatry 2004, 37:S39-S45.
7. Letmaier M., Painold A., Holl A.K., et al. Hyponatraemia during psychopharmacological treatment: results of a drug surveillance programme. Int J Neuropsychopharmacol 2012, 15(6):739-748.
8. Coupland C., Dhiman P., Morriss R., Arthur A., Barton G., Hippisley-Cox J. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. Br Med J 2011, 343.
9. Coupland C.A., Dhiman P., Barton G., et al. A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database. Health Technol Assess 2011, 15(28):1-202. [iii-iv].
10. Siegler E.L., Tamres D., Berlin J.A., Allentaylor L., Strom B.L. Risk-factors for the development of hyponatremia in psychiatric-inpatients. Arch Intern Med 1995, 155(9):953-957.
11. Kirby D., Harrigan S., Ames D. Hyponatraemia in elderly psychiatric patients treated with selective serotonin reuptake inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit. Int J Geriatr Psychiatry 2002, 17(3):231-237.
12. Liu B.A., Mittmann N., Knowles S.R., Shear N.H. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports. Can Med Assoc J 1996, 155(5):519-527.
13. Roxanas M., Hibbert E., Field M. Venlafaxine hyponatraemia: incidence, mechanism and management. Aust N Z J Psychiatry 2007, 41(5):411-418.
14. Jung Y.E., Jun T.Y., Kim K.S., Bahk W.M. Hyponatremia associated with selective serotonin reuptake inhibitors, mirtazapine and venlafaxine, in Korean patients with major depressive disorder. Int J Clin Pharmacol Ther 2011, 49(7):437-443.
15. Choi J.S., Lee H.W., Lee J.Y., Jung H.Y. Rapid-onset hyponatremia induced by duloxetine in a middle-aged male with depression and somatic symptoms. Psychiatry Invest 2012, 9(1):83-84.
16. Dirks A.C., van Hyfte D.M. Recurrent hyponatremia after substitution of citalopram with duloxetine. J Clin Psychopharmacol 2007, 27(3):313.
17. Harter C., Obier C., Eikelmann B. Delayed hyponatremia under duloxetine-a case report. Psychopharmakotherapie 2008, 15(1):27-29.
18. Kruger S., Lindstaedt M. Duloxetine and hyponatremia: a report of 5 cases. J Clin Psychopharmacol 2007, 27(1):101-104.
19. Li R.M., Wang C., Liu Z.W., Zhao B. A case of severe hyponatremia induced by duloxetine and ziprasidone. Chin Med J 2012, 125(20):3750-3751.
20. Mussig K., Morike K., Haring H. Severe and symptomatic hyponatremia following duloxetine treatment. J Psychopharmacol 2009, 23:3338-3339.
21. Safdieh J.E., Rudominer R. A case of hyponatremia induced by duloxetine. J Clin Psychopharmacol 2006, 26(6):675-676.
22. Stovall R., Brahm N.C., Crosby K.M. Recurrent episodes of serotonin-reuptake inhibitor-mediated hyponatremia in an elderly patient. Consult Pharm 2009, 24(10):765-768.
23. Spigset O., Hedenmalm K. Hyponatremia during treatment with clomipramine, perphenazine, or clozapine: study of therapeutic drug monitoring samples. J Clin Psychopharmacol 1996, 16(5):412-414.
24. Bavbek N., Kargili A., Akcay A., Kaya A. Recurrent hyponatremia associated with citalopram and mirtazapine. Am J Kid Dis 2006, 48(4):e61-e62.
25. Cheah C.Y., Ladhams B., Fegan P.G. Mirtazapine associated with profound hyponatremia: two case reports. Am J Geriatr Pharmacother 2008, 6(2):91-95.
26. Ladino M., Guardiola V.D., Paniagua M. Mirtazapine-induced hyponatremia in an elderly hospice patient. J Palliat Med 2006, 9(2):258-260.
27. Roxanas M.G. Mirtazapine-induced hyponatraemia. Med J Aust 2003, 179(8):453-454.
28. Famularo G., Gasbarrone L., De Virgilio A., Minisola G. Mirtazapine-associated hyponatremia in an elderly patient. Ann Pharmacother 2009, 43(6):1144-1145.
29. Marin-Ruiz A., Gu F., Brennan M. Cascading drug errors-hyponatremia followed by hypernatremia: mirtazapine-induced SIADH and volume depletion from demeclocycline. J Am Geriatr Soc 2009, 57:S18-S19.
30. Mogi T., Yoshino A., Ikemoto G., Nomura S. Mirtazapine as an alternative for selective-serotonin-reuptake-inhibitor-induced syndrome of inappropriate secretion of antidiuretic hormone. Psychiatry Clin Neurosci 2012, 66(1):80.
31. Jagsch C., Marksteiner J., Seiringer E., Windhager E. Successful mirtazapine treatment of an 81-year-old patient with syndrome of inappropriate antidiuretic hormone secretion. Pharmacopsychiatry 2007, 40(3):129-131.
32. Abdelrahman N., Kleinman Y., Rund D., Da'as N. Hyponatremia associated with the initiation of reboxetine therapy. Eur J Clin Pharmacol 2003, 59(2):177.
33. Koelkebeck K., Domschke K., Zwanzger P., Hetzel G., Lang D., Arolt V. A case of non-SIADH-induced hyponatremia in depression after treatment with reboxetine. World J Biol Psychiatry 2009, 10(4 Pt 2):609-611.
34. Ranieri P., Franzoni S., Trabucchi M. Reboxetine and hyponatremia. N Engl J Med 2000, 342(3):215-216.
35. Bagley S.C., Yaeger D. Hyponatremia associated with bupropion, a case verified by rechallenge. J Clin Psychopharmacol 2005, 25(1):98-99.
36. Kate N., Grover S., Kumar S., Modi M. Bupropion-induced hyponatremia. Gen Hosp Psychiatry 2013, 35(6):681. [e11-e12].
37. Kim C.S., Choi J.S., Bae E.H., Kim S.W. Hyponatremia associated with bupropion. Electrolyte Blood Press 2011, 9(1):23-26.
38. Liskin B., Walsh B.T., Roose S.P., Jackson W. Imipramine-induced inappropriate ADH secretion. J Clin Psychopharmacol 1984, 4(3):146-147.
39. Cerimele J.M., Robinson L.A. Sertraline-associated hyponatremia and subsequent tolerability of bupropion in an elderly woman. Prim Care Companion CNS Disord 2011, 13(5). PCC.1101175.
40. Malik A.R., Wolf P.K., Ravasia S. Recurrent paroxetine-induced hyponatremia. Can J Psychiatry 2004, 49(11):785.
41. Mercier S., Harry P., Merit J., Gamelin L. Severe hyponatremia induced by moclobemide. Therapie 1997, 52(1):82-83.
42. Fichman M.P., Simkin B., Karpf D. Hyponatremia secondary to a monoamine-oxidase (MAO) inhibitor, isocarboxazid, simulating the syndrome of inappropriate anti-diuretic hormone secretion (SIADH). Clin Res 1982, 30(1). [A107-A].
43. Peterson J., Pollack R., Mahoney J. Inappropriate antidiuretic hormone secondary to a monamine oxidase inhibitor. J Am Med Assoc 1978, 239(14):1422-1423.
44. Kirby D., Ames D. Hyponatraemia and selective serotonin re-uptake inhibitors in elderly patients. Int J Geriatr Psychiatry 2001, 16(5):484-493.
45. Movig K.L.L., Leufkens H.G.M., Lenderink A.W., et al. Association between antidepressant drug use and hyponatraemia: a case-control study. Br J Clin Pharmacol 2002, 53(4):363-369.
46. Movig K.L.L., Leufkens H.G.M., Lenderink A.W., Egberts A.C.G. Serotonergic antidepressants associated with an increased risk for hyponatraemia in the elderly. Eur J Clin Pharmacol 2001, 58(2):143-148.
47. Brownfield M., Greathouse J., Lorens S., Armstrong J., Urban J., Van de Kar L. Neuropharmacological characterization of serotoninergic stimulation of vasopressin secretion in conscious rats. Neuroendocrinology 1988, 47:277-283.
48. Leibowitz S., Eidelman D., Suh J., Diaz S., Sladek C. Mapping study of noradrenergic stimulation of vasopressinrelease. Exp Neurol 1990, 110:298-305.
49. Wilkinson T.J., Begg E.J., Winter A.C., Sainsbury R. Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people. Br J Clin Pharmacol 1999, 47(2):211-217.
50. Fabian T.J., Amico J.A., Kroboth P.D., et al. Paroxetine-induced hyponatremia in older adults: a 12-week prospective study. Arch Intern Med 2004, 164(3):327-332.
51. Bouman W.P., Pinner G., Johnson H. Incidence of selective serotonin reuptake inhibitor (SSRI) induced hyponatraemia due to the syndrome of inappropriate antidiuretic hormone (SIADH) secretion in the elderly. Int J Geriatr Psychiatry 1998, 13(1):12-15.
52. Huyse F.J., Zwaan W.A., Kupka R. The applicability of antidepressants in the depressed medically ill-an open clinical-trial with fluoxetine. J Psychosom Res 1994, 38(7):695-703.
53. Oslin D.W., Ten Have T.R., Streim J.E., et al. Probing the safety of medications in the frail elderly: evidence from a randomized clinical trial of sertraline and venlafaxine in depressed nursing home residents. J Clin Psychiatry 2003, 64(8):875-882.
54. Wee R., Lim W.K. Selective serotonin re-uptake inhibitors (SSRIs) and hyponatraemia in the elderly. Int J Geriatr Psychiatry 2004, 19(6):590-591.
55. Strachan J., Shepherd J. Hyponatraemia associated with the use of selective serotonin re-uptake inhibitors. Aust N Z J Psychiatry 1998, 32(2):295-298.
56. Fabian T.J., Amico J.A., Kroboth P.D., Mulsant B.H., Reynolds C.F., Pollock B.G. Paroxetine-induced hyponatremia in the elderly due to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J Geriatr Psychiatry Neurol 2003, 16(3):160-164.